Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Feature Articles
3/27/2024
BIOSECURE Act May Implicate WuXi-Produced Drugs in the US Market
3/27/2024
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies (WSJ...
3/26/2024
China Plays Down Concerns Over State Health Insurance Scheme, But Ques...
3/26/2024
Anti-China Bills Portend Massive Blow to Biotech: BioCentury Survey (B...
3/26/2024
Chinese Biotechs See Cash Again; Late-stage Assets Most Attractive (th...
3/25/2024
Chinese ADC Developers Unveil More Target Combos In Bispecific Drive (...
3/25/2024
Lilly CEO Reaffirms Commitment to Chinese Market amid US Threat agains...
3/20/2024
China Ranked Top Potential Biopharma Outsourcing Destination (Bioproce...
3/19/2024
Perspectives on 2024's Two Sessions (NCUSCR)
3/19/2024
Genscript Losses Shrink on Strong Growth for Cancer Cell Therapy (Bamb...
3/18/2024
The US and Chinese Biopharma Contractors (Science)
3/15/2024
Major Life Sciences Licensing Deal Trends in China in 2023 (Supra)
3/13/2024
Navigating China's Biologics Approval And Accelerated Pathways (Clinic...
3/13/2024
WuXi Became a Critical Partner to Biopharma Companies. They're Not Rea...
3/12/2024
Global Pharmaceutical Investment in Asia: A Strategic Focus Amidst Evo...
3/11/2024
Startups Raised Millions to In-license Drugs to China. Then the Model ...
3/10/2024
China Biopharma Tracker – February 2024 (PharmaNJ)
3/8/2024
BeiGene Still Bleeding Red Ink Despite Blockbuster Drug (Bamboo Works)
3/7/2024
Time To 'Cut Off' US Outbound Investment in China Biotech Firms Like B...
3/7/2024
Lessons from China's 2023 National Negotiation of Drug Prices (NLR)
3/6/2024
Weight Loss Drugs Threatened by US Effort to Contain China (Bloomberg)
3/5/2024
China Biopharma Tracker – January 2024 (PharmaNJ)
3/4/2024
IQVIA: China Closes Gap with the U.S. in New Drug Approvals
3/1/2024
Lab Monkey Prices Plunge in China as Drug Research Slows (FT)
2/26/2024
Chinese Pharma Turns to Global Deals to Cure Capital Crunch (Caixin Gl...
2/22/2024
New Trade Patterns in 2023: Cars, Chemicals, and China (AEI)
2/21/2024
U.S. Biotech Is in for a Protracted Divorce From China (Bioprocess Onl...
2/20/2024
Ozempic Is Taking Off With the World's Largest Obese Population (Hint:...
2/19/2024
AZ CEO: China Has Become Fundamental Part of Pharma Industry (Bloomber...
2/16/2024
As U.S.-China Biotech Tensions Rise, Korea Holds Its Breath (Korean Jo...
Page:
1
/
7
Total number of articles:
195
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit